her2-trastuzumab-pdb-2022

Creator: Sol De Leon Cruz, Amber Herrod, Katherine H. Park and Amy Wu Wu; David S. Goodsell and Stephen K. Burley / RCSB Protein Data Bank
Identity: HER2 with the antibody trastuzumab, illustrated for PDB-101 in April 2022. Trastuzumab forms part of the treatment backbone; the image does not depict tucatinib or show a treatment result.
Original source page: https://pdb101.rcsb.org/motm/268
Original asset: https://cdn.rcsb.org/pdb101/motm/268/Figure1.jpg
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/)
Reuse basis: RCSB usage policy explicitly licenses Molecule of the Month illustrations CC BY4.0 and requests Goodsell/RCSB attribution. The original article identifies four primary illustrators and names all six authors in its April2022 footer; the full credit retains both.
Original SHA-256: 32ea0acf56f16b9fdba507b3358cc7e3fe4e5606021417126b861aa2702c3322
Original dimensions: 457 × 700
Checked at: 2026-10-09T20:03:42.812Z
Modifications: none; display resizing only.
Editorial limitation: Specifically shows a component of the reported combination and the HER2 molecular target, not a generic medical photograph.

Served SHA-256: 32ea0acf56f16b9fdba507b3358cc7e3fe4e5606021417126b861aa2702c3322
Served dimensions: 457 × 700